Eloxx Pharmaceuticals, Inc. Common Stock vs. Kymera Therapeutics, Inc. Common Stock
ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
$18.76 -1.63%
VS KYMRKymera Therapeutics, Inc. Common Stock
$117.39 +2.60%
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| ELOX | KYMR | |
|---|---|---|
| Market Cap | $64.47 million | $9.76 billion |
| Revenue (TTM) | — | $105.00 million |
| Net Income (TTM) | — | $-299,601,000 |
KYMR leads on 1 of 1 size & scale factors.
Valuation
| ELOX | KYMR | |
|---|---|---|
| Price / Book | 1.39 | 6.47 |
| Price / Sales | — | 92.96 |
ELOX leads on 1 of 1 valuation factors.
Profitability
| ELOX | KYMR | |
|---|---|---|
| Net Margin | — | -285.34% |
| Return on Equity | — | -19.85% |
ELOX and KYMR split the profitability factors evenly.
Risk & Sentiment
| ELOX | KYMR | |
|---|---|---|
| Short Interest | 0.01% | 0.24% |
ELOX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ELOX overview, ELOX financials, KYMR overview, KYMR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.